Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

News Opinion CV Team Dispatch

November 2021 News Roundup

L.A. McKeown

November 01, 2021

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Daily News

血流动力学指导的补液可减少肾病和心衰患者的造影剂肾病

Todd Neale

December 09, 2015

News Daily News

El Guiado Hemodinámico de la Hidratación Reduce la Nefropatía por Contraste en Pacientes con Enfermedad Renal, Insuficiencia Cardíaca

Todd Neale

December 09, 2015

News Industry News

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

August 31, 2015

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

News Conference News

Osmolality, Viscosity Make No DIRECT Difference in Contrast Nephropathy

Jason Kahn

May 18, 2011

CME

Advertisement

November 2021 News Roundup

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

血流动力学指导的补液可减少肾病和心衰患者的造影剂肾病

El Guiado Hemodinámico de la Hidratación Reduce la Nefropatía por Contraste en Pacientes con Enfermedad Renal, Insuficiencia Cardíaca

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

Novel Anticoagulants Showing Benefits in A-fib Subgroups

Osmolality, Viscosity Make No DIRECT Difference in Contrast Nephropathy

Latest Data in Renal Denervation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content